CXCL12 is constitutively released in various organs, including the lung, brain, liver, skeletal muscle, heart, skin, kidney and bone marrow, and it promotes ischaemic tissue revascularization and tumour development [86,87]. Here, CXCL12 is linked to neoplasm.